Kymera Therapeutics is Named one of the FierceBiotech's Fierce 15 Companies of 2019
Por um escritor misterioso
Descrição
/PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company advancing the field of targeted protein degradation to create next generation medicines
Outlook 2023 - Biotech 360°: A slow starter blasting off into a
Yahoo Finance - Stock Market Live, Quotes, Business & Finance News
SEC Filing Kymera Therapeutics, Inc.
Fierce Biotech Names Tvardi Therapeutics as One of its “Fierce 15
Kymera shows us the technologies that enable the development of
SEC Filing — Vigil Neuroscience, Inc
Ventus Therapeutics Named a “Fierce 15” Biotech Company of 2023
SEC Filing - Prelude Therapeutics
Kymera Therapeutics Announces First Patient Dosed in Phase 2
de
por adulto (o preço varia de acordo com o tamanho do grupo)
